nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—CYP2C9—brain cancer	0.703	1	CbGaD
Tapentadol—CYP2D6—Lomustine—brain cancer	0.0383	0.569	CbGbCtD
Tapentadol—CYP2D6—Hydroxyurea—brain cancer	0.029	0.431	CbGbCtD
Tapentadol—HTR3A—fourth ventricle—brain cancer	0.0178	0.217	CbGeAlD
Tapentadol—HTR3A—cranial nerve—brain cancer	0.00634	0.0774	CbGeAlD
Tapentadol—OPRM1—telencephalic ventricle—brain cancer	0.00473	0.0577	CbGeAlD
Tapentadol—OPRD1—ganglion—brain cancer	0.00431	0.0527	CbGeAlD
Tapentadol—HTR3A—ganglion—brain cancer	0.00321	0.0392	CbGeAlD
Tapentadol—Balance disorder—Procarbazine—brain cancer	0.00298	0.0227	CcSEcCtD
Tapentadol—OPRM1—ganglion—brain cancer	0.00294	0.0359	CbGeAlD
Tapentadol—Dysarthria—Lomustine—brain cancer	0.00271	0.0206	CcSEcCtD
Tapentadol—SLC6A4—ganglion—brain cancer	0.00245	0.0299	CbGeAlD
Tapentadol—SLC6A2—ganglion—brain cancer	0.00215	0.0263	CbGeAlD
Tapentadol—Altered state of consciousness—Temozolomide—brain cancer	0.00213	0.0162	CcSEcCtD
Tapentadol—Disorientation—Lomustine—brain cancer	0.00208	0.0158	CcSEcCtD
Tapentadol—Visual disturbance—Lomustine—brain cancer	0.00196	0.015	CcSEcCtD
Tapentadol—Lethargy—Lomustine—brain cancer	0.0019	0.0145	CcSEcCtD
Tapentadol—Osteoarthritis—Lomustine—brain cancer	0.00186	0.0142	CcSEcCtD
Tapentadol—SLC6A4—hindbrain—brain cancer	0.00186	0.0227	CbGeAlD
Tapentadol—Ataxia—Lomustine—brain cancer	0.00175	0.0133	CcSEcCtD
Tapentadol—Dysarthria—Procarbazine—brain cancer	0.00172	0.0131	CcSEcCtD
Tapentadol—OPRD1—telencephalon—brain cancer	0.00166	0.0203	CbGeAlD
Tapentadol—Nightmare—Procarbazine—brain cancer	0.00157	0.012	CcSEcCtD
Tapentadol—HTR3A—brainstem—brain cancer	0.00139	0.017	CbGeAlD
Tapentadol—Lung disorder—Temozolomide—brain cancer	0.00139	0.0106	CcSEcCtD
Tapentadol—UGT1A9—endocrine gland—brain cancer	0.00133	0.0162	CbGeAlD
Tapentadol—Disorientation—Procarbazine—brain cancer	0.00132	0.0101	CcSEcCtD
Tapentadol—OPRM1—brainstem—brain cancer	0.00128	0.0156	CbGeAlD
Tapentadol—Memory impairment—Temozolomide—brain cancer	0.00125	0.00955	CcSEcCtD
Tapentadol—Visual impairment—Lomustine—brain cancer	0.00124	0.00945	CcSEcCtD
Tapentadol—HTR3A—telencephalon—brain cancer	0.00124	0.0151	CbGeAlD
Tapentadol—Lethargy—Procarbazine—brain cancer	0.00121	0.00918	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.0012	0.00911	CcSEcCtD
Tapentadol—Disturbance in attention—Temozolomide—brain cancer	0.00114	0.00865	CcSEcCtD
Tapentadol—OPRM1—telencephalon—brain cancer	0.00113	0.0139	CbGeAlD
Tapentadol—Thinking abnormal—Carmustine—brain cancer	0.00111	0.00847	CcSEcCtD
Tapentadol—Ataxia—Procarbazine—brain cancer	0.00111	0.00846	CcSEcCtD
Tapentadol—Drug interaction—Carmustine—brain cancer	0.0011	0.00836	CcSEcCtD
Tapentadol—UGT2B7—endocrine gland—brain cancer	0.00107	0.0131	CbGeAlD
Tapentadol—SLC6A4—brainstem—brain cancer	0.00106	0.013	CbGeAlD
Tapentadol—Infection—Carboplatin—brain cancer	0.00104	0.00791	CcSEcCtD
Tapentadol—Coordination abnormal—Carmustine—brain cancer	0.00104	0.0079	CcSEcCtD
Tapentadol—OPRD1—head—brain cancer	0.00104	0.0127	CbGeAlD
Tapentadol—Disorientation—Hydroxyurea—brain cancer	0.00102	0.00778	CcSEcCtD
Tapentadol—Coordination abnormal—Temozolomide—brain cancer	0.001	0.00763	CcSEcCtD
Tapentadol—OPRK1—head—brain cancer	0.000993	0.0121	CbGeAlD
Tapentadol—Depressed level of consciousness—Carmustine—brain cancer	0.000984	0.00749	CcSEcCtD
Tapentadol—Depressed level of consciousness—Temozolomide—brain cancer	0.000951	0.00724	CcSEcCtD
Tapentadol—OPRD1—central nervous system—brain cancer	0.000946	0.0116	CbGeAlD
Tapentadol—Pollakiuria—Procarbazine—brain cancer	0.000944	0.00718	CcSEcCtD
Tapentadol—SLC6A4—telencephalon—brain cancer	0.000944	0.0115	CbGeAlD
Tapentadol—SLC6A2—brainstem—brain cancer	0.000936	0.0114	CbGeAlD
Tapentadol—Infection—Lomustine—brain cancer	0.000909	0.00692	CcSEcCtD
Tapentadol—OPRK1—central nervous system—brain cancer	0.000907	0.0111	CbGeAlD
Tapentadol—CYP2D6—hindbrain—brain cancer	0.000894	0.0109	CbGeAlD
Tapentadol—OPRK1—cerebellum—brain cancer	0.000886	0.0108	CbGeAlD
Tapentadol—Mental disability—Carmustine—brain cancer	0.000884	0.00673	CcSEcCtD
Tapentadol—Mental disability—Temozolomide—brain cancer	0.000854	0.0065	CcSEcCtD
Tapentadol—SLC6A2—telencephalon—brain cancer	0.000831	0.0101	CbGeAlD
Tapentadol—Breast disorder—Hydroxyurea—brain cancer	0.000827	0.00629	CcSEcCtD
Tapentadol—OPRM1—midbrain—brain cancer	0.000815	0.00995	CbGeAlD
Tapentadol—Hallucination—Procarbazine—brain cancer	0.000814	0.00619	CcSEcCtD
Tapentadol—Decreased appetite—Lomustine—brain cancer	0.000795	0.00605	CcSEcCtD
Tapentadol—OPRM1—spinal cord—brain cancer	0.000795	0.00971	CbGeAlD
Tapentadol—HTR3A—head—brain cancer	0.000771	0.00941	CbGeAlD
Tapentadol—Hot flush—Temozolomide—brain cancer	0.000764	0.00581	CcSEcCtD
Tapentadol—Menopausal symptoms—Temozolomide—brain cancer	0.000757	0.00576	CcSEcCtD
Tapentadol—OPRD1—brain—brain cancer	0.000751	0.00917	CbGeAlD
Tapentadol—Chills—Procarbazine—brain cancer	0.000734	0.00558	CcSEcCtD
Tapentadol—OPRK1—brain—brain cancer	0.00072	0.00879	CbGeAlD
Tapentadol—OPRM1—endocrine gland—brain cancer	0.000716	0.00874	CbGeAlD
Tapentadol—OPRM1—head—brain cancer	0.000707	0.00863	CbGeAlD
Tapentadol—Infestation—Hydroxyurea—brain cancer	0.000705	0.00537	CcSEcCtD
Tapentadol—Infestation NOS—Hydroxyurea—brain cancer	0.000705	0.00537	CcSEcCtD
Tapentadol—HTR3A—central nervous system—brain cancer	0.000703	0.00859	CbGeAlD
Tapentadol—Tension—Procarbazine—brain cancer	0.000699	0.00532	CcSEcCtD
Tapentadol—Ataxia—Carmustine—brain cancer	0.000695	0.00529	CcSEcCtD
Tapentadol—SLC6A2—gonad—brain cancer	0.000693	0.00847	CbGeAlD
Tapentadol—Nervousness—Procarbazine—brain cancer	0.000691	0.00526	CcSEcCtD
Tapentadol—SLC6A4—midbrain—brain cancer	0.000678	0.00828	CbGeAlD
Tapentadol—Ataxia—Temozolomide—brain cancer	0.000672	0.00511	CcSEcCtD
Tapentadol—Tremor—Procarbazine—brain cancer	0.000667	0.00508	CcSEcCtD
Tapentadol—SLC6A4—spinal cord—brain cancer	0.000661	0.00808	CbGeAlD
Tapentadol—SLC6A2—medulla oblongata—brain cancer	0.000653	0.00797	CbGeAlD
Tapentadol—Breast disorder—Temozolomide—brain cancer	0.000646	0.00492	CcSEcCtD
Tapentadol—OPRM1—central nervous system—brain cancer	0.000645	0.00788	CbGeAlD
Tapentadol—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000644	0.0049	CcSEcCtD
Tapentadol—Syncope—Procarbazine—brain cancer	0.000638	0.00486	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00063	0.0048	CcSEcCtD
Tapentadol—Hallucination—Hydroxyurea—brain cancer	0.00063	0.00479	CcSEcCtD
Tapentadol—Loss of consciousness—Procarbazine—brain cancer	0.000626	0.00476	CcSEcCtD
Tapentadol—Cough—Procarbazine—brain cancer	0.000621	0.00473	CcSEcCtD
Tapentadol—Convulsion—Procarbazine—brain cancer	0.000617	0.00469	CcSEcCtD
Tapentadol—Arthralgia—Procarbazine—brain cancer	0.000606	0.00461	CcSEcCtD
Tapentadol—Anxiety—Procarbazine—brain cancer	0.000604	0.0046	CcSEcCtD
Tapentadol—SLC6A4—endocrine gland—brain cancer	0.000595	0.00727	CbGeAlD
Tapentadol—Dry mouth—Procarbazine—brain cancer	0.000593	0.00451	CcSEcCtD
Tapentadol—SLC6A4—head—brain cancer	0.000588	0.00718	CbGeAlD
Tapentadol—Confusional state—Procarbazine—brain cancer	0.000586	0.00446	CcSEcCtD
Tapentadol—Vomiting—Lomustine—brain cancer	0.000582	0.00443	CcSEcCtD
Tapentadol—Oedema—Procarbazine—brain cancer	0.000581	0.00442	CcSEcCtD
Tapentadol—Infection—Procarbazine—brain cancer	0.000577	0.00439	CcSEcCtD
Tapentadol—Angiopathy—Hydroxyurea—brain cancer	0.000574	0.00437	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Temozolomide—brain cancer	0.000574	0.00437	CcSEcCtD
Tapentadol—Shock—Procarbazine—brain cancer	0.000572	0.00435	CcSEcCtD
Tapentadol—Pollakiuria—Temozolomide—brain cancer	0.000571	0.00434	CcSEcCtD
Tapentadol—Erectile dysfunction—Temozolomide—brain cancer	0.000569	0.00433	CcSEcCtD
Tapentadol—Depression—Carmustine—brain cancer	0.000568	0.00432	CcSEcCtD
Tapentadol—Chills—Hydroxyurea—brain cancer	0.000568	0.00432	CcSEcCtD
Tapentadol—Tachycardia—Procarbazine—brain cancer	0.000567	0.00432	CcSEcCtD
Tapentadol—Hyperhidrosis—Procarbazine—brain cancer	0.000562	0.00427	CcSEcCtD
Tapentadol—Weight decreased—Temozolomide—brain cancer	0.000559	0.00425	CcSEcCtD
Tapentadol—HTR3A—brain—brain cancer	0.000558	0.00682	CbGeAlD
Tapentadol—Urinary tract infection—Carmustine—brain cancer	0.000554	0.00422	CcSEcCtD
Tapentadol—Infestation NOS—Temozolomide—brain cancer	0.000551	0.00419	CcSEcCtD
Tapentadol—Infestation—Temozolomide—brain cancer	0.000551	0.00419	CcSEcCtD
Tapentadol—Depression—Temozolomide—brain cancer	0.000549	0.00418	CcSEcCtD
Tapentadol—Nausea—Lomustine—brain cancer	0.000544	0.00414	CcSEcCtD
Tapentadol—Hypotension—Procarbazine—brain cancer	0.000543	0.00413	CcSEcCtD
Tapentadol—SLC6A4—central nervous system—brain cancer	0.000536	0.00655	CbGeAlD
Tapentadol—Urinary tract infection—Temozolomide—brain cancer	0.000535	0.00407	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000529	0.00403	CcSEcCtD
Tapentadol—Insomnia—Procarbazine—brain cancer	0.000525	0.004	CcSEcCtD
Tapentadol—SLC6A2—endocrine gland—brain cancer	0.000524	0.0064	CbGeAlD
Tapentadol—Paraesthesia—Procarbazine—brain cancer	0.000522	0.00397	CcSEcCtD
Tapentadol—SLC6A2—head—brain cancer	0.000517	0.00632	CbGeAlD
Tapentadol—Somnolence—Procarbazine—brain cancer	0.000516	0.00393	CcSEcCtD
Tapentadol—CYP2D6—brainstem—brain cancer	0.000513	0.00626	CbGeAlD
Tapentadol—OPRM1—brain—brain cancer	0.000512	0.00626	CbGeAlD
Tapentadol—Hallucination—Carmustine—brain cancer	0.000509	0.00387	CcSEcCtD
Tapentadol—Hypoaesthesia—Carmustine—brain cancer	0.000509	0.00387	CcSEcCtD
Tapentadol—Decreased appetite—Procarbazine—brain cancer	0.000505	0.00384	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Etoposide—brain cancer	0.000504	0.00384	CcSEcCtD
Tapentadol—Connective tissue disorder—Carmustine—brain cancer	0.000503	0.00383	CcSEcCtD
Tapentadol—Fatigue—Procarbazine—brain cancer	0.000501	0.00381	CcSEcCtD
Tapentadol—Constipation—Procarbazine—brain cancer	0.000497	0.00378	CcSEcCtD
Tapentadol—CYP2C19—endocrine gland—brain cancer	0.000493	0.00603	CbGeAlD
Tapentadol—Visual impairment—Carmustine—brain cancer	0.000493	0.00375	CcSEcCtD
Tapentadol—Hypoaesthesia—Temozolomide—brain cancer	0.000492	0.00374	CcSEcCtD
Tapentadol—Hallucination—Temozolomide—brain cancer	0.000492	0.00374	CcSEcCtD
Tapentadol—Urinary tract disorder—Temozolomide—brain cancer	0.000488	0.00372	CcSEcCtD
Tapentadol—Connective tissue disorder—Temozolomide—brain cancer	0.000486	0.0037	CcSEcCtD
Tapentadol—Urethral disorder—Temozolomide—brain cancer	0.000485	0.00369	CcSEcCtD
Tapentadol—Feeling abnormal—Procarbazine—brain cancer	0.000479	0.00364	CcSEcCtD
Tapentadol—Eye disorder—Carmustine—brain cancer	0.000478	0.00364	CcSEcCtD
Tapentadol—Convulsion—Hydroxyurea—brain cancer	0.000477	0.00363	CcSEcCtD
Tapentadol—Visual impairment—Temozolomide—brain cancer	0.000476	0.00363	CcSEcCtD
Tapentadol—SLC6A2—central nervous system—brain cancer	0.000472	0.00577	CbGeAlD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000466	0.00354	CcSEcCtD
Tapentadol—Eye disorder—Temozolomide—brain cancer	0.000462	0.00352	CcSEcCtD
Tapentadol—Urticaria—Procarbazine—brain cancer	0.000462	0.00351	CcSEcCtD
Tapentadol—Cardiac disorder—Temozolomide—brain cancer	0.000459	0.00349	CcSEcCtD
Tapentadol—CYP2D6—telencephalon—brain cancer	0.000455	0.00556	CbGeAlD
Tapentadol—Oedema—Hydroxyurea—brain cancer	0.00045	0.00342	CcSEcCtD
Tapentadol—Angiopathy—Temozolomide—brain cancer	0.000449	0.00341	CcSEcCtD
Tapentadol—Mental disorder—Carmustine—brain cancer	0.000448	0.00341	CcSEcCtD
Tapentadol—Infection—Hydroxyurea—brain cancer	0.000447	0.0034	CcSEcCtD
Tapentadol—Immune system disorder—Temozolomide—brain cancer	0.000447	0.0034	CcSEcCtD
Tapentadol—Mediastinal disorder—Temozolomide—brain cancer	0.000446	0.00339	CcSEcCtD
Tapentadol—Malnutrition—Carmustine—brain cancer	0.000445	0.00339	CcSEcCtD
Tapentadol—Chills—Temozolomide—brain cancer	0.000444	0.00338	CcSEcCtD
Tapentadol—Nervous system disorder—Hydroxyurea—brain cancer	0.000441	0.00336	CcSEcCtD
Tapentadol—Infestation NOS—Etoposide—brain cancer	0.000441	0.00335	CcSEcCtD
Tapentadol—Infestation—Etoposide—brain cancer	0.000441	0.00335	CcSEcCtD
Tapentadol—Skin disorder—Hydroxyurea—brain cancer	0.000437	0.00332	CcSEcCtD
Tapentadol—Mental disorder—Temozolomide—brain cancer	0.000433	0.0033	CcSEcCtD
Tapentadol—Malnutrition—Temozolomide—brain cancer	0.00043	0.00328	CcSEcCtD
Tapentadol—Hypersensitivity—Procarbazine—brain cancer	0.000428	0.00326	CcSEcCtD
Tapentadol—SLC6A4—brain—brain cancer	0.000426	0.0052	CbGeAlD
Tapentadol—Vision blurred—Carmustine—brain cancer	0.00042	0.00319	CcSEcCtD
Tapentadol—Tremor—Carmustine—brain cancer	0.000417	0.00318	CcSEcCtD
Tapentadol—Asthenia—Procarbazine—brain cancer	0.000417	0.00317	CcSEcCtD
Tapentadol—Pruritus—Procarbazine—brain cancer	0.000411	0.00313	CcSEcCtD
Tapentadol—Agitation—Carmustine—brain cancer	0.000409	0.00311	CcSEcCtD
Tapentadol—Vision blurred—Temozolomide—brain cancer	0.000406	0.00309	CcSEcCtD
Tapentadol—Tremor—Temozolomide—brain cancer	0.000403	0.00307	CcSEcCtD
Tapentadol—Dyspnoea—Hydroxyurea—brain cancer	0.000401	0.00305	CcSEcCtD
Tapentadol—Somnolence—Hydroxyurea—brain cancer	0.0004	0.00304	CcSEcCtD
Tapentadol—Diarrhoea—Procarbazine—brain cancer	0.000398	0.00303	CcSEcCtD
Tapentadol—Dyspepsia—Hydroxyurea—brain cancer	0.000396	0.00301	CcSEcCtD
Tapentadol—Agitation—Temozolomide—brain cancer	0.000396	0.00301	CcSEcCtD
Tapentadol—Hypoaesthesia—Etoposide—brain cancer	0.000394	0.003	CcSEcCtD
Tapentadol—Angioedema—Temozolomide—brain cancer	0.000393	0.00299	CcSEcCtD
Tapentadol—Decreased appetite—Hydroxyurea—brain cancer	0.000391	0.00297	CcSEcCtD
Tapentadol—Urinary tract disorder—Etoposide—brain cancer	0.000391	0.00297	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000388	0.00295	CcSEcCtD
Tapentadol—Urethral disorder—Etoposide—brain cancer	0.000388	0.00295	CcSEcCtD
Tapentadol—Fatigue—Hydroxyurea—brain cancer	0.000388	0.00295	CcSEcCtD
Tapentadol—Vertigo—Temozolomide—brain cancer	0.000387	0.00294	CcSEcCtD
Tapentadol—Convulsion—Carmustine—brain cancer	0.000386	0.00294	CcSEcCtD
Tapentadol—Constipation—Hydroxyurea—brain cancer	0.000385	0.00293	CcSEcCtD
Tapentadol—Dizziness—Procarbazine—brain cancer	0.000384	0.00292	CcSEcCtD
Tapentadol—CYP2C9—endocrine gland—brain cancer	0.000382	0.00467	CbGeAlD
Tapentadol—Palpitations—Temozolomide—brain cancer	0.00038	0.00289	CcSEcCtD
Tapentadol—Anxiety—Carmustine—brain cancer	0.000378	0.00288	CcSEcCtD
Tapentadol—Cough—Temozolomide—brain cancer	0.000376	0.00286	CcSEcCtD
Tapentadol—SLC6A2—brain—brain cancer	0.000375	0.00458	CbGeAlD
Tapentadol—Convulsion—Temozolomide—brain cancer	0.000373	0.00284	CcSEcCtD
Tapentadol—Feeling abnormal—Hydroxyurea—brain cancer	0.000371	0.00282	CcSEcCtD
Tapentadol—Eye disorder—Etoposide—brain cancer	0.00037	0.00281	CcSEcCtD
Tapentadol—Vomiting—Procarbazine—brain cancer	0.000369	0.00281	CcSEcCtD
Tapentadol—Cardiac disorder—Etoposide—brain cancer	0.000367	0.00279	CcSEcCtD
Tapentadol—Confusional state—Carmustine—brain cancer	0.000367	0.00279	CcSEcCtD
Tapentadol—Arthralgia—Temozolomide—brain cancer	0.000366	0.00279	CcSEcCtD
Tapentadol—Rash—Procarbazine—brain cancer	0.000366	0.00279	CcSEcCtD
Tapentadol—Dermatitis—Procarbazine—brain cancer	0.000366	0.00279	CcSEcCtD
Tapentadol—Anxiety—Temozolomide—brain cancer	0.000365	0.00278	CcSEcCtD
Tapentadol—Headache—Procarbazine—brain cancer	0.000364	0.00277	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000364	0.00277	CcSEcCtD
Tapentadol—Oedema—Carmustine—brain cancer	0.000363	0.00277	CcSEcCtD
Tapentadol—Infection—Carmustine—brain cancer	0.000361	0.00275	CcSEcCtD
Tapentadol—Angiopathy—Etoposide—brain cancer	0.000359	0.00273	CcSEcCtD
Tapentadol—Dry mouth—Temozolomide—brain cancer	0.000358	0.00273	CcSEcCtD
Tapentadol—Immune system disorder—Etoposide—brain cancer	0.000357	0.00272	CcSEcCtD
Tapentadol—Mediastinal disorder—Etoposide—brain cancer	0.000357	0.00271	CcSEcCtD
Tapentadol—Chills—Etoposide—brain cancer	0.000355	0.0027	CcSEcCtD
Tapentadol—Tachycardia—Carmustine—brain cancer	0.000355	0.0027	CcSEcCtD
Tapentadol—Confusional state—Temozolomide—brain cancer	0.000354	0.0027	CcSEcCtD
Tapentadol—Anaphylactic shock—Temozolomide—brain cancer	0.000351	0.00267	CcSEcCtD
Tapentadol—Oedema—Temozolomide—brain cancer	0.000351	0.00267	CcSEcCtD
Tapentadol—Infection—Temozolomide—brain cancer	0.000349	0.00266	CcSEcCtD
Tapentadol—Nausea—Procarbazine—brain cancer	0.000345	0.00263	CcSEcCtD
Tapentadol—Nervous system disorder—Temozolomide—brain cancer	0.000344	0.00262	CcSEcCtD
Tapentadol—Skin disorder—Temozolomide—brain cancer	0.000341	0.0026	CcSEcCtD
Tapentadol—Hypotension—Carmustine—brain cancer	0.00034	0.00258	CcSEcCtD
Tapentadol—Hyperhidrosis—Temozolomide—brain cancer	0.00034	0.00258	CcSEcCtD
Tapentadol—Hypersensitivity—Hydroxyurea—brain cancer	0.000331	0.00252	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Carmustine—brain cancer	0.000331	0.00252	CcSEcCtD
Tapentadol—Insomnia—Carmustine—brain cancer	0.000329	0.0025	CcSEcCtD
Tapentadol—Paraesthesia—Carmustine—brain cancer	0.000326	0.00248	CcSEcCtD
Tapentadol—Dyspnoea—Carmustine—brain cancer	0.000324	0.00247	CcSEcCtD
Tapentadol—Somnolence—Carmustine—brain cancer	0.000323	0.00246	CcSEcCtD
Tapentadol—Asthenia—Hydroxyurea—brain cancer	0.000323	0.00246	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00032	0.00244	CcSEcCtD
Tapentadol—Insomnia—Temozolomide—brain cancer	0.000318	0.00242	CcSEcCtD
Tapentadol—Decreased appetite—Carmustine—brain cancer	0.000316	0.0024	CcSEcCtD
Tapentadol—Paraesthesia—Temozolomide—brain cancer	0.000315	0.0024	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Carmustine—brain cancer	0.000314	0.00239	CcSEcCtD
Tapentadol—Dyspnoea—Temozolomide—brain cancer	0.000313	0.00238	CcSEcCtD
Tapentadol—Somnolence—Temozolomide—brain cancer	0.000312	0.00238	CcSEcCtD
Tapentadol—Constipation—Carmustine—brain cancer	0.000311	0.00237	CcSEcCtD
Tapentadol—Vertigo—Etoposide—brain cancer	0.000309	0.00235	CcSEcCtD
Tapentadol—Dyspepsia—Temozolomide—brain cancer	0.000309	0.00235	CcSEcCtD
Tapentadol—Diarrhoea—Hydroxyurea—brain cancer	0.000308	0.00234	CcSEcCtD
Tapentadol—Decreased appetite—Temozolomide—brain cancer	0.000305	0.00232	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000303	0.00231	CcSEcCtD
Tapentadol—Fatigue—Temozolomide—brain cancer	0.000303	0.0023	CcSEcCtD
Tapentadol—Loss of consciousness—Etoposide—brain cancer	0.000303	0.0023	CcSEcCtD
Tapentadol—Cough—Etoposide—brain cancer	0.000301	0.00229	CcSEcCtD
Tapentadol—Constipation—Temozolomide—brain cancer	0.0003	0.00229	CcSEcCtD
Tapentadol—Feeling abnormal—Carmustine—brain cancer	0.0003	0.00228	CcSEcCtD
Tapentadol—Convulsion—Etoposide—brain cancer	0.000298	0.00227	CcSEcCtD
Tapentadol—Dizziness—Hydroxyurea—brain cancer	0.000297	0.00226	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000291	0.00222	CcSEcCtD
Tapentadol—Feeling abnormal—Temozolomide—brain cancer	0.000289	0.0022	CcSEcCtD
Tapentadol—UGT1A9—Irinotecan Pathway—APC—brain cancer	0.000287	0.0179	CbGpPWpGaD
Tapentadol—CYP2D6—endocrine gland—brain cancer	0.000287	0.00351	CbGeAlD
Tapentadol—Vomiting—Hydroxyurea—brain cancer	0.000286	0.00218	CcSEcCtD
Tapentadol—Rash—Hydroxyurea—brain cancer	0.000284	0.00216	CcSEcCtD
Tapentadol—Confusional state—Etoposide—brain cancer	0.000283	0.00216	CcSEcCtD
Tapentadol—CYP2D6—head—brain cancer	0.000283	0.00346	CbGeAlD
Tapentadol—Dermatitis—Hydroxyurea—brain cancer	0.000283	0.00216	CcSEcCtD
Tapentadol—Headache—Hydroxyurea—brain cancer	0.000282	0.00214	CcSEcCtD
Tapentadol—Anaphylactic shock—Etoposide—brain cancer	0.000281	0.00214	CcSEcCtD
Tapentadol—Infection—Etoposide—brain cancer	0.000279	0.00213	CcSEcCtD
Tapentadol—Urticaria—Temozolomide—brain cancer	0.000279	0.00212	CcSEcCtD
Tapentadol—Tachycardia—Etoposide—brain cancer	0.000274	0.00209	CcSEcCtD
Tapentadol—Skin disorder—Etoposide—brain cancer	0.000273	0.00208	CcSEcCtD
Tapentadol—Hyperhidrosis—Etoposide—brain cancer	0.000272	0.00207	CcSEcCtD
Tapentadol—Hypersensitivity—Carmustine—brain cancer	0.000268	0.00204	CcSEcCtD
Tapentadol—Nausea—Hydroxyurea—brain cancer	0.000267	0.00203	CcSEcCtD
Tapentadol—Hypotension—Etoposide—brain cancer	0.000263	0.002	CcSEcCtD
Tapentadol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000263	0.0163	CbGpPWpGaD
Tapentadol—Asthenia—Carmustine—brain cancer	0.000261	0.00198	CcSEcCtD
Tapentadol—Hypersensitivity—Temozolomide—brain cancer	0.000259	0.00197	CcSEcCtD
Tapentadol—CYP2D6—central nervous system—brain cancer	0.000259	0.00316	CbGeAlD
Tapentadol—CYP2D6—cerebellum—brain cancer	0.000253	0.00309	CbGeAlD
Tapentadol—Paraesthesia—Etoposide—brain cancer	0.000252	0.00192	CcSEcCtD
Tapentadol—Asthenia—Temozolomide—brain cancer	0.000252	0.00192	CcSEcCtD
Tapentadol—Dyspnoea—Etoposide—brain cancer	0.000251	0.00191	CcSEcCtD
Tapentadol—Somnolence—Etoposide—brain cancer	0.00025	0.0019	CcSEcCtD
Tapentadol—Diarrhoea—Carmustine—brain cancer	0.000249	0.00189	CcSEcCtD
Tapentadol—Pruritus—Temozolomide—brain cancer	0.000249	0.00189	CcSEcCtD
Tapentadol—Decreased appetite—Etoposide—brain cancer	0.000244	0.00186	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Etoposide—brain cancer	0.000243	0.00185	CcSEcCtD
Tapentadol—Fatigue—Etoposide—brain cancer	0.000242	0.00184	CcSEcCtD
Tapentadol—Dizziness—Carmustine—brain cancer	0.00024	0.00183	CcSEcCtD
Tapentadol—Constipation—Etoposide—brain cancer	0.00024	0.00183	CcSEcCtD
Tapentadol—Diarrhoea—Temozolomide—brain cancer	0.00024	0.00183	CcSEcCtD
Tapentadol—Dizziness—Temozolomide—brain cancer	0.000232	0.00177	CcSEcCtD
Tapentadol—Feeling abnormal—Etoposide—brain cancer	0.000232	0.00176	CcSEcCtD
Tapentadol—Vomiting—Carmustine—brain cancer	0.000231	0.00176	CcSEcCtD
Tapentadol—Rash—Carmustine—brain cancer	0.000229	0.00174	CcSEcCtD
Tapentadol—Dermatitis—Carmustine—brain cancer	0.000229	0.00174	CcSEcCtD
Tapentadol—Headache—Carmustine—brain cancer	0.000228	0.00173	CcSEcCtD
Tapentadol—Vomiting—Temozolomide—brain cancer	0.000223	0.0017	CcSEcCtD
Tapentadol—Urticaria—Etoposide—brain cancer	0.000223	0.0017	CcSEcCtD
Tapentadol—Rash—Temozolomide—brain cancer	0.000221	0.00169	CcSEcCtD
Tapentadol—Dermatitis—Temozolomide—brain cancer	0.000221	0.00168	CcSEcCtD
Tapentadol—Headache—Temozolomide—brain cancer	0.00022	0.00167	CcSEcCtD
Tapentadol—Nausea—Carmustine—brain cancer	0.000216	0.00164	CcSEcCtD
Tapentadol—Nausea—Temozolomide—brain cancer	0.000209	0.00159	CcSEcCtD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000207	0.0129	CbGpPWpGaD
Tapentadol—Hypersensitivity—Etoposide—brain cancer	0.000207	0.00158	CcSEcCtD
Tapentadol—CYP2D6—brain—brain cancer	0.000205	0.00251	CbGeAlD
Tapentadol—Asthenia—Etoposide—brain cancer	0.000202	0.00153	CcSEcCtD
Tapentadol—Pruritus—Etoposide—brain cancer	0.000199	0.00151	CcSEcCtD
Tapentadol—Diarrhoea—Etoposide—brain cancer	0.000192	0.00146	CcSEcCtD
Tapentadol—Dizziness—Etoposide—brain cancer	0.000186	0.00141	CcSEcCtD
Tapentadol—UGT1A9—PPAR Alpha Pathway—CDK4—brain cancer	0.000186	0.0116	CbGpPWpGaD
Tapentadol—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000184	0.0114	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000179	0.0111	CbGpPWpGaD
Tapentadol—Vomiting—Etoposide—brain cancer	0.000179	0.00136	CcSEcCtD
Tapentadol—Rash—Etoposide—brain cancer	0.000177	0.00135	CcSEcCtD
Tapentadol—Dermatitis—Etoposide—brain cancer	0.000177	0.00135	CcSEcCtD
Tapentadol—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000177	0.011	CbGpPWpGaD
Tapentadol—Headache—Etoposide—brain cancer	0.000176	0.00134	CcSEcCtD
Tapentadol—SLC6A4—Circadian rythm related genes—NTRK3—brain cancer	0.000175	0.0109	CbGpPWpGaD
Tapentadol—Nausea—Etoposide—brain cancer	0.000167	0.00127	CcSEcCtD
Tapentadol—HTR3A—Ion channel transport—TRPC6—brain cancer	0.000165	0.0103	CbGpPWpGaD
Tapentadol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000159	0.00988	CbGpPWpGaD
Tapentadol—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000157	0.00975	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00015	0.00934	CbGpPWpGaD
Tapentadol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000146	0.00909	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—CYP2C9—brain cancer	0.000146	0.00905	CbGpPWpGaD
Tapentadol—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000144	0.00897	CbGpPWpGaD
Tapentadol—UGT1A9—Metapathway biotransformation—CYP2C9—brain cancer	0.000144	0.00893	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000141	0.00879	CbGpPWpGaD
Tapentadol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000129	0.00801	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—S100A10—brain cancer	0.000124	0.00774	CbGpPWpGaD
Tapentadol—UGT1A9—PPAR Alpha Pathway—CCND1—brain cancer	0.00012	0.00746	CbGpPWpGaD
Tapentadol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000118	0.00737	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—HES1—brain cancer	0.00011	0.00682	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—PTCH2—brain cancer	0.000102	0.00632	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—VAV1—brain cancer	9.98e-05	0.0062	CbGpPWpGaD
Tapentadol—OPRM1—IL4-mediated signaling events—IRS2—brain cancer	9.66e-05	0.00601	CbGpPWpGaD
Tapentadol—UGT1A9—PPAR Alpha Pathway—MYC—brain cancer	9.62e-05	0.00599	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—OR14C36—brain cancer	8.91e-05	0.00554	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—OR4C12—brain cancer	8.91e-05	0.00554	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—PTCH2—brain cancer	8.91e-05	0.00554	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—ESR2—brain cancer	8.82e-05	0.00548	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—OR4C12—brain cancer	8.09e-05	0.00503	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—OR14C36—brain cancer	8.09e-05	0.00503	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—OR14C36—brain cancer	7.81e-05	0.00486	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—OR4C12—brain cancer	7.81e-05	0.00486	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.8e-05	0.00485	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—PTCH2—brain cancer	7.53e-05	0.00468	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—OR14C36—brain cancer	7.1e-05	0.00441	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—OR4C12—brain cancer	7.1e-05	0.00441	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—HES1—brain cancer	6.85e-05	0.00426	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—CYP2C9—brain cancer	6.84e-05	0.00425	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	6.75e-05	0.0042	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	6.68e-05	0.00415	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—OR14C36—brain cancer	6.6e-05	0.00411	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—OR4C12—brain cancer	6.6e-05	0.00411	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—CYP2C9—brain cancer	6.29e-05	0.00391	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	6.2e-05	0.00386	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—OR4C12—brain cancer	6e-05	0.00373	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—OR14C36—brain cancer	6e-05	0.00373	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.96e-05	0.00371	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—SIRT1—brain cancer	5.8e-05	0.00361	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—TRPC6—brain cancer	5.75e-05	0.00358	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.59e-05	0.00348	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.5e-05	0.00342	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—SHH—brain cancer	5.23e-05	0.00326	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PTCH2—brain cancer	5.21e-05	0.00324	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—SMO—brain cancer	4.96e-05	0.00309	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—PTCH1—brain cancer	4.96e-05	0.00309	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—RELA—brain cancer	4.95e-05	0.00308	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.84e-05	0.00301	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—OR14C36—brain cancer	4.78e-05	0.00297	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—OR4C12—brain cancer	4.78e-05	0.00297	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—SHH—brain cancer	4.59e-05	0.00286	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PTCH2—brain cancer	4.57e-05	0.00284	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—ABR—brain cancer	4.51e-05	0.0028	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—CDK4—brain cancer	4.38e-05	0.00273	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—PTCH1—brain cancer	4.35e-05	0.00271	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—SMO—brain cancer	4.35e-05	0.00271	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OR14C36—brain cancer	4.19e-05	0.00261	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OR4C12—brain cancer	4.19e-05	0.00261	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—ABR—brain cancer	4.09e-05	0.00255	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.09e-05	0.00254	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DTX2—brain cancer	4.06e-05	0.00253	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—ABR—brain cancer	3.95e-05	0.00246	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—SHH—brain cancer	3.88e-05	0.00241	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PTCH2—brain cancer	3.86e-05	0.0024	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—SMO—brain cancer	3.68e-05	0.00229	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—PTCH1—brain cancer	3.68e-05	0.00229	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—ABR—brain cancer	3.59e-05	0.00223	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DTX2—brain cancer	3.56e-05	0.00222	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OR14C36—brain cancer	3.54e-05	0.0022	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OR4C12—brain cancer	3.54e-05	0.0022	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.43e-05	0.00214	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—ABR—brain cancer	3.34e-05	0.00208	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.08e-05	0.00192	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTCH2—brain cancer	3.08e-05	0.00192	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP2C9—brain cancer	3.06e-05	0.0019	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—ABR—brain cancer	3.03e-05	0.00189	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.02e-05	0.00188	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DTX2—brain cancer	3.01e-05	0.00187	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HES5—brain cancer	2.98e-05	0.00186	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STRADA—brain cancer	2.9e-05	0.0018	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	2.85e-05	0.00177	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTCH2—brain cancer	2.7e-05	0.00168	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—SHH—brain cancer	2.69e-05	0.00167	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.63e-05	0.00163	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HES5—brain cancer	2.62e-05	0.00163	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—BSG—brain cancer	2.6e-05	0.00162	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TRPC6—brain cancer	2.59e-05	0.00161	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PTCH1—brain cancer	2.55e-05	0.00158	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—SMO—brain cancer	2.55e-05	0.00158	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STRADA—brain cancer	2.54e-05	0.00158	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	2.5e-05	0.00156	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP2C9—brain cancer	2.49e-05	0.00155	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ABR—brain cancer	2.42e-05	0.0015	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—SHH—brain cancer	2.36e-05	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GLI2—brain cancer	2.33e-05	0.00145	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTCH2—brain cancer	2.28e-05	0.00142	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TRPC6—brain cancer	2.27e-05	0.00141	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—IDH1—brain cancer	2.24e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—SMO—brain cancer	2.23e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PTCH1—brain cancer	2.23e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HES5—brain cancer	2.21e-05	0.00138	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GLI1—brain cancer	2.19e-05	0.00137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STRADA—brain cancer	2.15e-05	0.00134	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—VAV1—brain cancer	2.14e-05	0.00133	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ABR—brain cancer	2.12e-05	0.00132	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—BSG—brain cancer	2.12e-05	0.00132	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	2.11e-05	0.00131	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SUFU—brain cancer	2.08e-05	0.00129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GLI2—brain cancer	2.05e-05	0.00127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GFAP—brain cancer	2.01e-05	0.00125	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—SHH—brain cancer	1.99e-05	0.00124	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—VAV1—brain cancer	1.94e-05	0.00121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GLI1—brain cancer	1.92e-05	0.0012	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.92e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TRPC6—brain cancer	1.92e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HEY1—brain cancer	1.9e-05	0.00118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PTCH1—brain cancer	1.89e-05	0.00117	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—SMO—brain cancer	1.89e-05	0.00117	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—VAV1—brain cancer	1.87e-05	0.00117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DLL1—brain cancer	1.87e-05	0.00116	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—TP53—brain cancer	1.86e-05	0.00116	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SUFU—brain cancer	1.82e-05	0.00113	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—IDH1—brain cancer	1.82e-05	0.00113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ABR—brain cancer	1.79e-05	0.00111	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ENO2—brain cancer	1.77e-05	0.0011	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GFAP—brain cancer	1.76e-05	0.00109	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.75e-05	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GLI2—brain cancer	1.73e-05	0.00108	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—VAV1—brain cancer	1.7e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HEY1—brain cancer	1.67e-05	0.00104	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DLL1—brain cancer	1.64e-05	0.00102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GLI1—brain cancer	1.63e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SHH—brain cancer	1.59e-05	0.000987	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—VAV1—brain cancer	1.58e-05	0.000985	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SUFU—brain cancer	1.54e-05	0.000959	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TRPC6—brain cancer	1.53e-05	0.000952	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SMO—brain cancer	1.5e-05	0.000936	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTCH1—brain cancer	1.5e-05	0.000936	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GFAP—brain cancer	1.49e-05	0.000925	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.48e-05	0.000922	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—VAV1—brain cancer	1.44e-05	0.000895	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ENO2—brain cancer	1.44e-05	0.000895	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HEY1—brain cancer	1.41e-05	0.000877	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SHH—brain cancer	1.39e-05	0.000866	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DLL1—brain cancer	1.38e-05	0.00086	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	1.36e-05	0.000844	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TRPC6—brain cancer	1.34e-05	0.000835	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTCH1—brain cancer	1.32e-05	0.000821	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMO—brain cancer	1.32e-05	0.000821	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	1.23e-05	0.000767	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH2—brain cancer	1.2e-05	0.000748	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.19e-05	0.00074	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SHH—brain cancer	1.18e-05	0.000731	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2C9—brain cancer	1.17e-05	0.000727	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VAV1—brain cancer	1.15e-05	0.000713	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.13e-05	0.000705	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.11e-05	0.000693	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMO—brain cancer	1.11e-05	0.000693	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	1.08e-05	0.000672	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2C9—brain cancer	1.08e-05	0.000669	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH2—brain cancer	1.05e-05	0.000656	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.01e-05	0.000626	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000625	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—BSG—brain cancer	9.94e-06	0.000619	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HES1—brain cancer	9.86e-06	0.000613	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—brain cancer	9.55e-06	0.000594	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PDGFRA—brain cancer	9.39e-06	0.000584	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—BSG—brain cancer	9.15e-06	0.000569	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	9.13e-06	0.000568	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SPP1—brain cancer	9.11e-06	0.000567	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—BSG—brain cancer	9.07e-06	0.000564	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH2—brain cancer	8.91e-06	0.000554	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—brain cancer	8.67e-06	0.000539	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HES1—brain cancer	8.65e-06	0.000538	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—IDH1—brain cancer	8.55e-06	0.000532	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VAV1—brain cancer	8.5e-06	0.000528	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—brain cancer	8.37e-06	0.000521	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS2—brain cancer	8.24e-06	0.000513	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDGFRA—brain cancer	8.23e-06	0.000512	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CG—brain cancer	8.12e-06	0.000505	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SPP1—brain cancer	7.99e-06	0.000497	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—IDH1—brain cancer	7.87e-06	0.000489	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—IDH1—brain cancer	7.8e-06	0.000485	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—brain cancer	7.6e-06	0.000473	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HES1—brain cancer	7.31e-06	0.000455	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CG—brain cancer	7.28e-06	0.000453	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APC—brain cancer	7.28e-06	0.000453	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS2—brain cancer	7.23e-06	0.00045	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—brain cancer	7.08e-06	0.00044	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.96e-06	0.000433	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDGFRA—brain cancer	6.96e-06	0.000433	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ENO2—brain cancer	6.76e-06	0.00042	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SPP1—brain cancer	6.75e-06	0.00042	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EGFR—brain cancer	6.63e-06	0.000413	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CG—brain cancer	6.6e-06	0.00041	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—brain cancer	6.43e-06	0.0004	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APC—brain cancer	6.38e-06	0.000397	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CG—brain cancer	6.38e-06	0.000397	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.35e-06	0.000395	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ENO2—brain cancer	6.22e-06	0.000387	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ENO2—brain cancer	6.16e-06	0.000383	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS2—brain cancer	6.11e-06	0.00038	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EGFR—brain cancer	5.82e-06	0.000362	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RELA—brain cancer	5.69e-06	0.000354	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ERBB2—brain cancer	5.65e-06	0.000352	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CG—brain cancer	5.4e-06	0.000336	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APC—brain cancer	5.4e-06	0.000336	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—brain cancer	5.12e-06	0.000319	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCND1—brain cancer	4.99e-06	0.000311	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RELA—brain cancer	4.99e-06	0.00031	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ERBB2—brain cancer	4.96e-06	0.000308	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CTNNB1—brain cancer	4.95e-06	0.000308	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EGFR—brain cancer	4.92e-06	0.000306	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—brain cancer	4.49e-06	0.000279	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCND1—brain cancer	4.38e-06	0.000272	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—brain cancer	4.35e-06	0.000271	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CTNNB1—brain cancer	4.34e-06	0.00027	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—brain cancer	4.31e-06	0.000268	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RELA—brain cancer	4.22e-06	0.000262	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ERBB2—brain cancer	4.19e-06	0.000261	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—brain cancer	4.01e-06	0.000249	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGFR—brain cancer	3.92e-06	0.000244	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—brain cancer	3.82e-06	0.000237	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—brain cancer	3.8e-06	0.000236	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—brain cancer	3.78e-06	0.000235	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCND1—brain cancer	3.7e-06	0.00023	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CTNNB1—brain cancer	3.67e-06	0.000228	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—brain cancer	3.51e-06	0.000218	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGFR—brain cancer	3.44e-06	0.000214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—brain cancer	3.29e-06	0.000205	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—brain cancer	3.23e-06	0.000201	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—brain cancer	3.19e-06	0.000199	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CG—brain cancer	3.1e-06	0.000193	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—brain cancer	2.97e-06	0.000185	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGFR—brain cancer	2.9e-06	0.000181	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—brain cancer	2.88e-06	0.000179	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CG—brain cancer	2.85e-06	0.000177	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CG—brain cancer	2.83e-06	0.000176	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—brain cancer	2.44e-06	0.000152	CbGpPWpGaD
